SEAN PARKIN: Open Payments
NPI 1568686020 · SAN LEANDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 6 payments from 5 companies in 2025. Trend: 2023 $366 · 2024 $389 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $272 |
| Organon LLC | 1 | $168 |
| LEO Pharma Inc. | 1 | $137 |
| GENZYME CORPORATION | 1 | $130 |
| Lilly USA, LLC | 1 | $123 |
Products named: NEMLUVIO, VTAMA, ADBRY, DUPIXENT, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
